Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.95 USD | +1.01% | -0.19% | +95.11% |
05-02 | Dyne Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-30 | Morgan Stanley Starts Dyne Therapeutics With Overweight Rating, $40 Price Target | MT |
- Stock Market
- Equities
- DYN Stock
- News Dyne Therapeutics, Inc.
- MarketScreener Editorial Features